Nationwide #AreYourKidneysOK+? initiative expands access to subsidised blood screening, public education, and pharmacist support for 12,550 Malaysians.
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 19 August 2026 – As chronic conditions such as diabetes, cardiovascular disease and chronic kidney disease continue to affect Malaysians, early detection is becoming increasingly important in reducing complications and improving long-term health outcomes.
(From left: Dr. Cheng Yong Fatt (Consultant Nephrologist of KPJ Seremban Specialist Hospital); Dr. Svetlana Yanchuk (Country President of AstraZeneca Malaysia); Ph. Hiew Fei Tsong (Co-founder of Alpro Group); Dr. Ng Ming Lee (Medical Director of Alpro Clinic); Ms Jenny Poon (Business Unit Director of CVRM/R&I of AstraZeneca Malaysia); Dr. Yong Lit Sin (Consultant Endocrinologist of Columbia Asia Hospital Seremban)
These conditions are closely interconnected across the Cardio-Kidney-Metabolic spectrum, meaning that a problem affecting one area of health may also increase the risks to other parts of the body. However, many individuals may not recognise these risks until their condition has progressed or complications have developed.
One such complication is hyperkalemia, a condition characterised by elevated potassium levels in the blood. Hyperkalemia is more common among people living with chronic kidney disease because impaired kidneys may have lower ability to remove excess potassium from the body. As the condition may not always present noticeable warning signs, it remains under-recognised by the public and may lead to serious complications affecting the heart's rhythm if not appropriately identified and managed.
Recognising the need to strengthen early detection and public awareness across the Cardio-Kidney-Metabolic (CKM) spectrum, Alpro Group, in collaboration with AstraZeneca Malaysia, announced the launch of #AreYourKidneysOK+?, a nationwide awareness campaign dedicated to encourage early detection, promoting kidney health, and raising awareness of hyperkalemia.
This nationwide initiative aims to empower Malaysians to better understand the connection between their heart, kidney and metabolic health, while bringing greater attention to hyperkalemia as an often-overlooked complication associated with chronic kidney disease.
At the heart of the campaign is a subsidised blood screening programme aimed at encouraging more Malaysians to take an earlier and more proactive approach to their health. Eligible individuals will receive subsidy on selected blood test packages, to reduce financial barriers in screening and to support the earlier identification of potential Cardio-Kidney-Metabolic and health risks.
The campaign aims to reach 12,550 individuals across Malaysia, a shared commitment by Alpro Group and AstraZeneca Malaysia to turn public health awareness into meaningful action.
Beyond providing financial support for screening, the campaign creates a more accessible pathway for Malaysians to learn about their potential health risks, undergo appropriate screening and speak to their healthcare professionals about the next steps they may need to undertake.
To extend the campaign's reach beyond physical pharmacy locations, the initiative is supported by a dedicated digital health education platform containing trusted and easy-to-understand information about hyperkalemia, including its causes, risk factors, possible warning signs and relationship with chronic kidney disease.
The platform serves as a public health resource that Malaysians can access at any time, helping individuals and caregivers better understand hyperkalemia and prepare for more informed conversations with pharmacists, doctors and other healthcare professionals.
Through Alpro Group's community healthcare network, members of the public will also have greater access to pharmacist support and guidance. Alpro pharmacists can help individuals better understand the importance of screening, recognise relevant risk factors and seek appropriate medical assessment or follow-up when necessary.
"Many chronic health risks develop quietly and may only be discovered after complications have occurred. Through this campaign, we want to make preventive healthcare more accessible by connecting public education, affordable screening and professional healthcare support. By targeting 12,550 Malaysians, we hope to encourage more people to take an earlier and more proactive step towards understanding their heart, kidney and metabolic health," said Dr. Ng Ming Lee, Medical Director of Alpro Clinic.
"As chronic kidney disease remains a significant public health challenge in Malaysia, this collaboration reflects a shared commitment across the healthcare ecosystem to strengthen public awareness of kidney health and bring health education closer to the public. Through Alpro Group's nationwide network, we aim to help more Malaysians learn about relevant risk factors and have informed conversations with healthcare professionals to support appropriate assessment and follow-up," said Dr. Svetlana Yanchuk, Country President, AstraZeneca Malaysia.
Through this collaboration, Alpro Group and AstraZeneca Malaysia reaffirm their shared commitment to advancing preventive healthcare by combining greater public awareness, accessible screening and professional healthcare support.
The campaign also demonstrates the important role that community pharmacies can play in supporting wider public health efforts by providing Malaysians with convenient access to health education, early screening opportunities and trusted professional guidance within their communities.
Members of the public are encouraged to learn more about hyperkalemia by visiting www.alpropharmacy.com/pages/hyperkalemia or by speaking to an Alpro pharmacist.
References
1. KDIGO Controversies Conference. Potassium Homeostasis and Management of Dyskalemia in Kidney Diseases. Kidney International (2020). [kdigo.org]
2. National Kidney Foundation. High Potassium (Hyperkalemia): Causes, Symptoms, and Treatment (updated 2025).
Hashtag: #AlproPharmacy #AlproGroup #AreYourKidneysOK+?
The issuer is solely responsible for the content of this announcement.
About Alpro Group
Founded in 2002, Alpro Group's ecosystem has grown to include Alpro Pharmacy, Apotek Alpro, Alpro スギ (Sugi) Pharmacy, Alpro Physio, Alpro Clinic, Alpro Baby, Alpro OptiSaver, Alpro Audiology, Alpro Health, and Alpro Foundation. Supported by a team of more than 1,000 healthcare professionals, including doctors, pharmacists, nutritionists, dietitians, physiotherapists, optometrist and many others, Alpro serves over 5 million families in Malaysia and Indonesia through its extensive network of 500 physical outlets.
Alpro Pharmacy is the first and only community pharmacy in the region to offer product liability insurance of MYR 1 million in Malaysia and IDR 3 billion in Indonesia, ensuring the supply of genuine medications and enhancing consumer trust.
With the vision of a healthy and vibrant world, Alpro Group aims to become the No. 1 prescription pharmacy chain in Southeast Asia.
About AstraZeneca
AstraZeneca is a global, science led biopharmaceutical company focused on the discovery, development, and commercialisation of innovative medicines that transform patient outcomes. Headquartered in Cambridge, United Kingdom, the company operates in more than 100 countries and plays a significant role in advancing modern healthcare through research driven innovation and strategic partnerships worldwide.
Guided by its purpose to push the boundaries of science to deliver life changing medicines, AstraZeneca prioritises long term investment in research and development. The company's global strategy is built on deep scientific expertise, advanced technology platforms, and precision medicine approaches, including biologics, antibody drug conjugates, and data driven drug discovery. These capabilities enable AstraZeneca to address complex diseases and unmet medical needs with increasing accuracy and effectiveness.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
Exploring Emerging Opportunities in AI, Smart Supply Chain Management, ESG and Sustainability
Free Admission Open for Public Registration Now
HONG KONG SAR – Media OutReach Newswire – 24 October 2026 – Amid the reshaping of global supply chains, the rapid advancement of artificial intelligence (AI) technologies, and the rise of emerging industries such as the low-altitude economy, the logistics industry is entering a new wave of smart transformation. Organised by the Hong Kong Productivity Council (HKPC) and funded by the Logistics Promotion Funding Scheme (LPFS) under the Maritime and Aviation Training Fund of the Transport and Logistics Bureau of the HKSAR Government, LogTech Expo 2026 will take place on 29 October (Thursday) at the InnoCentre in Kowloon Tong. Under the theme "Smart-Driven Transformation, Leading the Future of Logistics", the Expo will bring together more than 50 logistics, supply chain and innovation and technology enterprises, alongside logistics industry leaders and experts, to share insights through a series of forums and discussions. The event will provide a one-stop platform for the industry to stay abreast of the latest logistics technology trends and developments. Admission is free, and online registration is now open.
As one of the major annual events in Hong Kong's logistics technology sector, the Expo will feature the latest applications and achievements in smart logistics. From AI and big data analytics, smart warehousing and robotics, and automated supply chain management systems, to cross-border e-commerce logistics, green logistics, new energy transportation and drone delivery solutions, visitors will be able to experience first-hand how technology is reshaping logistics operations and helping enterprises enhance efficiency and competitiveness.
Renowned Enterprises and Organisations Showcase the Entire Smart Logistics Value Chain
This year's Expo will bring together renowned brands and organisations from the logistics and technology sectors, including SF Supply Chain, Hong Kong Customs and Excise Department, Hongkong Post, Auto-ID Technology, HSM Industrial Solution, Tradelink, GS1 Hong Kong, ShipAny and Axis Communications, showcasing innovative solutions that support digital transformation and intelligent operations across the logistics industry. Visitors can explore the following technology zones:
- AI and Data Applications Zone: Leveraging AI, big data and automation technologies to enhance logistics planning and operational efficiency;
- Smart Warehousing and Robotics Zone: Showcasing intelligent sorting systems, automated warehousing and robotics solutions;
- Smart Supply Chain and Digital Platform Zone: Featuring WMS, TMS and digital supply chain management systems;
- Cross-border E-commerce and Delivery Zone: Showcasing innovative models in global fulfilment and smart delivery;
- ESG and Green Logistics Zone: Focusing on new energy transportation, carbon reduction technologies and sustainable logistics development;
- Low-Altitude Economy Zone: Exploring emerging applications such as drones and last-mile delivery solutions.
Visitors will not only be able to learn how innovative technologies are applied in real-world business scenarios but also engage directly with solution providers and industry experts to explore opportunities for collaboration and transformation.
10 Thematic Seminars and Sharing Sessions Focus on the Future of Logistics
In addition to the exhibition, the Expo will feature 10 thematic forums and technical sharing sessions covering key industry topics including AI, supply chain digitalisation, cross-border e-commerce, the low-altitude economy and logistics innovation.
The opening seminar, "Smart Tools for Logistics: Practical AI Applications and Insights", will be moderated by Ryan IP, Vice President and Executive Director of the Public Policy Institute of Our Hong Kong Foundation, and feature a panel comprising Professor Kee-hung LAI, Head of the Department of Logistics and Maritime Studies and Chair Professor of Shipping and Logistics at The Hong Kong Polytechnic University; Sunny HO, MH, JP, FCILT, Executive Director of the Hong Kong Shippers' Council; Keno Tai-yip CHEUNG, President of The Chartered Institute of Logistics and Transport in Hong Kong; and Suki CHEUNG Shuk-ming, Chief Executive Officer of MG Ship. Together, they will discuss how AI can enhance logistics operational efficiency, drive supply chain digitalisation, and support Hong Kong's development as a smart logistics hub.
In addition, experts from organisations including Profit Sky International Industrial, ShipAny, Tradelink, Axis Communications and GS1 Hong Kong will share real-life business cases, enabling visitors to gain deeper insights into digital twins, cross-border e-commerce, supply chain visibility and AI applications in logistics.
Promoting Cross-sector Collaboration to Shape the Future of Logistics
The Expo is supported by more than 20 industry organisations, including the Airport Authority Hong Kong, Cathay Cargo, Hong Kong Shippers' Council, Hong Kong Logistics Association, Chartered Institute of Logistics and Transport in Hong Kong, Cyberport and the Logistics and Supply Chain MultiTech R&D Centre. It serves as an effective platform for industry exchange and business matching, fostering innovative collaboration and industry upgrading.
Admission is free. Logistics practitioners, supply chain professionals, manufacturers, e-commerce businesses, technology solution providers, academics, and members of the public interested in the development of logistics technology are welcome to attend.
Event Details
LogTech Expo 2026
Date: 29 October 2026 (Thursday)
Time: 10:00 am - 5:30 pm
Venue: InnoCentre, 72 Tat Chee Avenue, Kowloon Tong
Admission Fee: Free (Advance registration required)
Register Now: https://campaigns.hkpc.org/zh-hk/tc-rsvp-logtech_expo_2026
Exhibitor List: View Exhibitor List
Hashtag: #HKPC
The issuer is solely responsible for the content of this announcement.
About the Hong Kong Productivity Council
The Hong Kong Productivity Council (HKPC) is a statutory body established in 1967, dedicated to enhancing the productivity and competitiveness of Hong Kong enterprises through world-class applied R&D, innovative technology services, and integrated manufacturing solutions. As a market-oriented, international R&D organisation, HKPC leverages its deep expertise and extensive industry experience in key areas such as AI, advanced manufacturing, life and health technology, green technology and new energy to drive new industrialisation and support the growth of emerging and future industries.
HKPC focuses on addressing businesses challenges and industrial technology needs, promoting the full integration between technological and industrial innovation. Through technology transfer, product innovation, intellectual property protection and commercialisation of R&D outcomes, the Council fosters collaboration with the local business community as well as top global R&D institutions, delivering added value to industries and advancing the development of new productive forces. HKPC's world-class R&D achievements have been widely recognised over the years, winning an array of local and overseas accolades, reinforcing Hong Kong's role as an international innovation and technology centre and a smart city.
To help enterprises capitalise on Hong Kong's strengths in international connectivity to expand into global markets, HKPC offers comprehensive overseas expansion services tailored to critical areas including product development, technology, manufacturing, and management, enabling businesses to successfully go global from Hong Kong.
HKPC is also committed to providing timely and practical support to SMEs and startups with timely and practical, assisting them in accessing Government funding programmes. Through its FutureSkills training initiatives, HKPC helps both industry and academia stay ahead in latest digital and STEM technologies, nurturing a future-ready talent pool for Hong Kong.
For more information, please visit HKPC's website: www.hkpc.org/en.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
